Promising ‘first’ in Alzheimer’s drug development
An international team of researchers have made a promising breakthrough in the development of drugs to treat Alzheimer’s Disease. For the first time, scientists have developed a drug that works on both major aggregation-promoting ‘hotspots’ of the Tau protein - addressing a critical gap in current treatments.
Writing in the journal Nature Neuroscience ... while the figure is thought to be around 7million in the US. Alzheimer's affects around six in 10 people with dementia. Memory problems, thinking ...
When the annual Walk to End Alzheimer’s began in Teague Park, Dan Keefe — a resident of Arabella of Longview Senior Living — ...
The S.E.C. alleged shortcomings in research said to support the drug, and its developer agreed to a $40 million settlement.
Leptin, a hormone that helps with weight control, also plays a role in normal cognition. Leptin resistance occurs when the ...
Managing dementia in the complex landscape of neurological disorders stands out as a formidable challenge, affecting millions ...
Dementia is often associated with memory loss - but there are several subtle signs that could indicate the condition, ...
Professionals and caregivers alike are invited to join the Alzheimer’s Association Michigan Chapter for its Upper Peninsula Conference Monday. Registration for the event is open now. The Upper ...
Alzheimer's disease is the most common type of dementia and is responsible for 60-70 per cent of dementia cases in people ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback